chr2-240030030-C-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001005853.1(OR6B2):​c.400G>A​(p.Val134Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000051 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

OR6B2
NM_001005853.1 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.650
Variant links:
Genes affected
OR6B2 (HGNC:15041): (olfactory receptor family 6 subfamily B member 2) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.046552867).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
OR6B2NM_001005853.1 linkuse as main transcriptc.400G>A p.Val134Ile missense_variant 1/1 ENST00000319423.5 NP_001005853.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
OR6B2ENST00000319423.5 linkuse as main transcriptc.400G>A p.Val134Ile missense_variant 1/1 NM_001005853.1 ENSP00000322435 P1

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151656
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000961
AC:
17
AN:
176904
Hom.:
0
AF XY:
0.000125
AC XY:
12
AN XY:
95738
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000114
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000782
Gnomad SAS exome
AF:
0.000406
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000406
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000509
AC:
63
AN:
1237244
Hom.:
0
Cov.:
18
AF XY:
0.0000563
AC XY:
35
AN XY:
622156
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000124
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000794
Gnomad4 SAS exome
AF:
0.000312
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000284
Gnomad4 OTH exome
AF:
0.0000567
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000659
AC:
1
AN:
151774
Hom.:
0
Cov.:
29
AF XY:
0.0000135
AC XY:
1
AN XY:
74180
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000959
Hom.:
0
ExAC
AF:
0.0000342
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 20, 2021The c.400G>A (p.V134I) alteration is located in exon 1 (coding exon 1) of the OR6B2 gene. This alteration results from a G to A substitution at nucleotide position 400, causing the valine (V) at amino acid position 134 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
11
DANN
Benign
0.96
DEOGEN2
Benign
0.0032
T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.076
N
LIST_S2
Benign
0.095
T
M_CAP
Benign
0.0029
T
MetaRNN
Benign
0.047
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.2
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.62
N
REVEL
Benign
0.091
Sift
Benign
0.13
T
Sift4G
Benign
0.24
T
Polyphen
0.019
B
Vest4
0.029
MutPred
0.30
Loss of catalytic residue at V134 (P = 0.0683);
MVP
0.15
MPC
0.55
ClinPred
0.020
T
GERP RS
4.4
Varity_R
0.088
gMVP
0.080

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs769139373; hg19: chr2-240969447; API